β2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure

Journal of the American Society of Nephrology

Volumn 15, Issue 2, 2004, Pages 316-325

  Nakamura, Akio ^a   Imaizumi, Akira ^a   Yanagawa, Yukishige ^a   Kohsaka, Takao ^b   Johns, Edward J ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Children's Medical   (Japan)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADENOVIRUS VECTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; ENDOTOXIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ENDOTOXEMIA; GENE OVEREXPRESSION; GENE THERAPY; GLOMERULUS FILTRATION RATE; INTRARENAL DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY INJURY; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SODIUM ABSORPTION; TRANSGENE; VIRUS PARTICLE;

EID: 0942287108     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000111247.76908.59     Document Type: Article

References (42)

1. Kaliner M, Schelhammer JH, Davis PB, Smith LJ, Venter JC: Autonomic nervous system abnormalities and allergy. Ann Intern Med 96: 349-357, 1982
2. Schelhammer JH, Marom Z, Kaliner M: Abnormal beta-adrenergic responsiveness in allergic subjects. II. The role of selective beta2-adrenergic hyporeactivity. J Allergy Clin Immunol 71: 57-61, 1983
3. Brodde OE: Beta-adrenoceptors in cardiac disease. Pharmacol Ther 60: 405-430, 1993
4. Ping P, Anzai T, Gao M, Hammond HK: Adenyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol 273: H707-H717, 1997
5. Silverman HJ, Penaranda R, Orens JB, Lee NH: Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to cathecholamines. Crit Care Med 21: 31-39, 1993
6. Bernardin G, Strosberg AD, Bernard B, Mattei M, Marullo S: β-Adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 24: 1315-1322, 1998
7. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ: Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268: R896-R901, 1995
8. Hetier P, Ayala J, Bousseau A, Prochiantz A: Modulation of interleukin-1 and tumor necrosis factor expression by beta adrenergic agonists in mouse ameboid microgial cells. Exp Brain Res 86: 407-413, 1991
9. 2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100: 1513-1519, 1997
10. Severn A, Rapson NT, Hunter CA, Liew FY: Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148: 3441-3445, 1992
11. 2-adrenoceptor prevents shiga toxin-induced tumour necrosis factor production. J Am Soc Nephrol 12: 2288-2299, 2001
12. Gluser MP, Zanetti G, Baumgartner J-D, Cohen J: Septic shock: Pathogenesis. Lancet 338: 732-736, 1991
13. Kaplan BS, Meyers KE, Schulman SL: The pathogeneis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 8: 1126-1133, 1998
14. Van De Kar NC, Monnens LA, Karmali MA, Van Hinsbergh VW: Tumour necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human vascular endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80: 2755-2764, 1992
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992
16. Stone R: Search for sepsis drugs goes on despite past failures. Science 264: 365-367, 1994
17. Warren HS: Strategies for the treatment of sepsis. N Engl J Med 336: 952-953, 1997
18. Zager RA: Escherichia coli endotoxin injections potentiate experimental ischemic renal injury. Am J Physiol 251: F988-994, 1986
19. Kikeri D, Pennel JP, Hwang KH, Jakob JI, Richman AV, Bourgigne JJ: Endotoxemic acute renal failure in awake rats. Am J Physiol 250: F1098-F1106, 1986
20. Schor N: Acute renal failure and the sepsis syndrome. Kidney Int 61: 764-776, 2002
21. th ed, edited by Feigin RD, Cherry JD, Philadelphia, WB Saunders, 1998, pp 807-820
22. Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute renal Failure Study Group. Kidney Int 66[Suppl]: S16-S24, 1998
23. Emilien G, Maloteaux J-M: Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol 53: 389-404, 1998
24. 2-adrenergic receptor gene delivery. J Clin Invest 104: 21-29, 1999
25. Ortiz PA, Hong NJ, Plato CF, Varela M, Garvin JL: An in vivo method for adenovirus-mediated transduction of thick ascending limbs. Kidney Int 63: 1141-1149, 2003
26. Lipkowitz MS, Hanss B, Tulchin N, Wilson PD, Langer JC, Ross MD, Kurtzman GJ, Klotman PE, Klotman ME: Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. J Am Soc Nephrol 10: 1908-1915, 1999
27. Kypson AP, Peppel K, Akhter SA, Lilly RE, Glower DD, Lefkowitz RJ, Koch WJ: Ex vivo adenovirus-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg 115: 623-630, 1998
28. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, Milano CA, Lefkowitz RJ: Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268: 1350-1353, 1995
29. Nakamura A, Johns EJ: Effect of renal nerves on expression of renin and angiotensinogen genes in rat kidneys. Am J Physiol 266: E230-E241, 1994
30. 2-adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin. Nephrol Dial Transplant 24: 1121-1129, 2000
31. Mayer SE, Stull JT, Wastila WB: Rapid tissue fixation and extraction techniques. Methods Enzymol 38: 1-9, 1974
32. Yang Y, Ertl HCJ, Wilson JM: MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433-442, 1994
33. Brown MJ, Brown DC, Murphy MB: Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414-1419, 1983
34. 2-adrenergic receptor mRNA expression along the hamster nephron segments. FEBS 318: 65-70, 1993
35. 2-adrenergic receptors in rat kidney. Kidney Int 59: 515-531, 2001
36. Rothwell NJ, Stock MJ, Sudera DK: Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol. Br J Pharmacol 90: 601-607, 1987
37. 2-adrenoceptor in endotoxin-stimulated renal macrophage cells. Kidney Int 56: 839-849, 1999
38. Verghese MW, Synyderman R: Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. J Immunol 130: 869-873, 1983
39. Begany DP, Carcillo JA, Herzer WA, Mi Z, Jackson EK: Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther 278: 37-41, 1996
40. Guan Z, Miller SB, Greenwald JE: Zaprinast accelerates recovery from established acute renal failure in the rat. Kidney Int 47: 1569-75, 1995
41. Schmidt W, Hacker A, Gebhard MM, Martin E, Schmit H: Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med 26: 1639-1645, 1998
42. Davies DC: Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200: 639-646, 2002